Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease

BACKGROUND: Fistulizing Crohn's disease (CD) presents a therapeutic challenge as fistulae are notoriously difficult to heal. Mycobacterium avium ss paratuberculosis (MAP) treatment in CD is gaining attention. AIM: We evaluated healing of CD fistula(e) using a novel combination therapy. STUDY: N...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Gaurav, Borody, Thomas, Turner, Robert, Leis, Sharyn, Campbell, Jordana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2015
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137971/
https://www.ncbi.nlm.nih.gov/pubmed/28031926
http://dx.doi.org/10.4155/fso.15.77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137971/
https://www.ncbi.nlm.nih.gov/pubmed/28031926
http://dx.doi.org/10.4155/fso.15.77

Ejemplares similares